Global In Vivo Toxicology Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 19147

In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.
In 2018, the global In Vivo Toxicology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global In Vivo Toxicology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Vivo Toxicology development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific
Danaher
Charles River Laboratories
Labcorp
The Jackson Laboratory
Data Sciences International
Envigo
Eurofins Scientific
Perkinelmer
SRI International
Taconic Biosciences
Wuxi Apptec

Market segment by Type, the product can be split into
Chronic Toxicity Testing
Sub-Chronic Toxicity Testing
Sub-Acute Toxicity Testing
Acute Toxicity Testing

Market segment by Application, split into
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity (DART)
Other Toxicity Endpoints

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global In Vivo Toxicology status, future forecast, growth opportunity, key market and key players.
To present the In Vivo Toxicology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of In Vivo Toxicology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global In Vivo Toxicology Market Size Growth Rate by Type (2014-2025)
1.4.2 Chronic Toxicity Testing
1.4.3 Sub-Chronic Toxicity Testing
1.4.4 Sub-Acute Toxicity Testing
1.4.5 Acute Toxicity Testing
1.5 Market by Application
1.5.1 Global In Vivo Toxicology Market Share by Application (2014-2025)
1.5.2 Immunotoxicity
1.5.3 Systemic Toxicity
1.5.4 Carcinogenicity
1.5.5 Genotoxicity
1.5.6 Developmental and Reproductive Toxicity (DART)
1.5.7 Other Toxicity Endpoints
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 In Vivo Toxicology Market Size
2.2 In Vivo Toxicology Growth Trends by Regions
2.2.1 In Vivo Toxicology Market Size by Regions (2014-2025)
2.2.2 In Vivo Toxicology Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 In Vivo Toxicology Market Size by Manufacturers
3.1.1 Global In Vivo Toxicology Revenue by Manufacturers (2014-2019)
3.1.2 Global In Vivo Toxicology Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global In Vivo Toxicology Market Concentration Ratio (CR5 and HHI)
3.2 In Vivo Toxicology Key Players Head office and Area Served
3.3 Key Players In Vivo Toxicology Product/Solution/Service
3.4 Date of Enter into In Vivo Toxicology Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global In Vivo Toxicology Market Size by Type (2014-2019)
4.2 Global In Vivo Toxicology Market Size by Application (2014-2019)

5 United States
5.1 United States In Vivo Toxicology Market Size (2014-2019)
5.2 In Vivo Toxicology Key Players in United States
5.3 United States In Vivo Toxicology Market Size by Type
5.4 United States In Vivo Toxicology Market Size by Application

6 Europe
6.1 Europe In Vivo Toxicology Market Size (2014-2019)
6.2 In Vivo Toxicology Key Players in Europe
6.3 Europe In Vivo Toxicology Market Size by Type
6.4 Europe In Vivo Toxicology Market Size by Application

7 China
7.1 China In Vivo Toxicology Market Size (2014-2019)
7.2 In Vivo Toxicology Key Players in China
7.3 China In Vivo Toxicology Market Size by Type
7.4 China In Vivo Toxicology Market Size by Application

8 Japan
8.1 Japan In Vivo Toxicology Market Size (2014-2019)
8.2 In Vivo Toxicology Key Players in Japan
8.3 Japan In Vivo Toxicology Market Size by Type
8.4 Japan In Vivo Toxicology Market Size by Application

9 Southeast Asia
9.1 Southeast Asia In Vivo Toxicology Market Size (2014-2019)
9.2 In Vivo Toxicology Key Players in Southeast Asia
9.3 Southeast Asia In Vivo Toxicology Market Size by Type
9.4 Southeast Asia In Vivo Toxicology Market Size by Application

10 India
10.1 India In Vivo Toxicology Market Size (2014-2019)
10.2 In Vivo Toxicology Key Players in India
10.3 India In Vivo Toxicology Market Size by Type
10.4 India In Vivo Toxicology Market Size by Application

11 Central & South America
11.1 Central & South America In Vivo Toxicology Market Size (2014-2019)
11.2 In Vivo Toxicology Key Players in Central & South America
11.3 Central & South America In Vivo Toxicology Market Size by Type
11.4 Central & South America In Vivo Toxicology Market Size by Application

12 International Players Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 In Vivo Toxicology Introduction
12.1.4 Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2014-2019)
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Danaher
12.2.1 Danaher Company Details
12.2.2 Company Description and Business Overview
12.2.3 In Vivo Toxicology Introduction
12.2.4 Danaher Revenue in In Vivo Toxicology Business (2014-2019)
12.2.5 Danaher Recent Development
12.3 Charles River Laboratories
12.3.1 Charles River Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 In Vivo Toxicology Introduction
12.3.4 Charles River Laboratories Revenue in In Vivo Toxicology Business (2014-2019)
12.3.5 Charles River Laboratories Recent Development
12.4 Labcorp
12.4.1 Labcorp Company Details
12.4.2 Company Description and Business Overview
12.4.3 In Vivo Toxicology Introduction
12.4.4 Labcorp Revenue in In Vivo Toxicology Business (2014-2019)
12.4.5 Labcorp Recent Development
12.5 The Jackson Laboratory
12.5.1 The Jackson Laboratory Company Details
12.5.2 Company Description and Business Overview
12.5.3 In Vivo Toxicology Introduction
12.5.4 The Jackson Laboratory Revenue in In Vivo Toxicology Business (2014-2019)
12.5.5 The Jackson Laboratory Recent Development
12.6 Data Sciences International
12.6.1 Data Sciences International Company Details
12.6.2 Company Description and Business Overview
12.6.3 In Vivo Toxicology Introduction
12.6.4 Data Sciences International Revenue in In Vivo Toxicology Business (2014-2019)
12.6.5 Data Sciences International Recent Development
12.7 Envigo
12.7.1 Envigo Company Details
12.7.2 Company Description and Business Overview
12.7.3 In Vivo Toxicology Introduction
12.7.4 Envigo Revenue in In Vivo Toxicology Business (2014-2019)
12.7.5 Envigo Recent Development
12.8 Eurofins Scientific
12.8.1 Eurofins Scientific Company Details
12.8.2 Company Description and Business Overview
12.8.3 In Vivo Toxicology Introduction
12.8.4 Eurofins Scientific Revenue in In Vivo Toxicology Business (2014-2019)
12.8.5 Eurofins Scientific Recent Development
12.9 Perkinelmer
12.9.1 Perkinelmer Company Details
12.9.2 Company Description and Business Overview
12.9.3 In Vivo Toxicology Introduction
12.9.4 Perkinelmer Revenue in In Vivo Toxicology Business (2014-2019)
12.9.5 Perkinelmer Recent Development
12.10 SRI International
12.10.1 SRI International Company Details
12.10.2 Company Description and Business Overview
12.10.3 In Vivo Toxicology Introduction
12.10.4 SRI International Revenue in In Vivo Toxicology Business (2014-2019)
12.10.5 SRI International Recent Development
12.11 Taconic Biosciences
12.12 Wuxi Apptec

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details